These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 411934)
1. Inhibitors of Bacillus subtilis DNA polymerase III. 6-(arylalkylamino)uracils and 6-anilinouracils. Brown NC; Gambino J; Wright GE J Med Chem; 1977 Sep; 20(9):1186-9. PubMed ID: 411934 [TBL] [Abstract][Full Text] [Related]
2. Inhibitors of Bacillus subtilis DNA polymerase III. 6-Anilinouracils and 6-(alkylamino)uracils. Wright GE; Brown NC J Med Chem; 1980 Jan; 23(1):34-8. PubMed ID: 6767030 [TBL] [Abstract][Full Text] [Related]
3. Inhibitors of Bacillus subtilis DNA polymerase III. Structure-activity relationships of 6-(phenylhydrazino)uracils. Wright GE; Brown NC J Med Chem; 1977 Sep; 20(9):1181-5. PubMed ID: 411933 [TBL] [Abstract][Full Text] [Related]
4. Quantitative structure-activity relationships of 6-anilinouracils as inhibitors of Bacillus subtilis DNA polymerase III. Wright GE; Gambino JJ J Med Chem; 1984 Feb; 27(2):181-5. PubMed ID: 6420570 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of substituted 6-anilinouracils and their inhibition of DNA polymerase IIIC and Gram-positive bacterial growth. Zhi C; Long ZY; Gambino J; Xu WC; Brown NC; Barnes M; Butler M; LaMarr W; Wright GE J Med Chem; 2003 Jun; 46(13):2731-9. PubMed ID: 12801236 [TBL] [Abstract][Full Text] [Related]
6. Inhibitors of Bacillus subtilis DNA polymerase III. Influence of modifications in the pyrimidine ring of anilino- and (benzylamino)pyrimidines. Trantolo DJ; Wright GE; Brown NC J Med Chem; 1986 May; 29(5):676-81. PubMed ID: 3084785 [TBL] [Abstract][Full Text] [Related]
7. 6-Anilinouracil-based inhibitors of Bacillus subtilis DNA polymerase III: antipolymerase and antimicrobial structure-activity relationships based on substitution at uracil N3. Tarantino PM; Zhi C; Gambino JJ; Wright GE; Brown NC J Med Chem; 1999 Jun; 42(11):2035-40. PubMed ID: 10354411 [TBL] [Abstract][Full Text] [Related]
8. Improved synthesis of antibacterial 3-substituted 6-anilinouracils. Svenstrup N; Kuhl A; Ehlert K; Häbich D Bioorg Med Chem Lett; 2008 Jun; 18(11):3215-8. PubMed ID: 18468893 [TBL] [Abstract][Full Text] [Related]
9. Inhibitors of DNA polymerase III as novel antimicrobial agents against gram-positive eubacteria. Tarantino PM; Zhi C; Wright GE; Brown NC Antimicrob Agents Chemother; 1999 Aug; 43(8):1982-7. PubMed ID: 10428923 [TBL] [Abstract][Full Text] [Related]
10. Butylanilinouracil: a selective inhibitor of HeLa cell DNA synthesis and HeLa cell DNA polymerase alpha. Wright GE; Baril EF; Brown NC Nucleic Acids Res; 1980 Jan; 8(1):99-109. PubMed ID: 6153466 [TBL] [Abstract][Full Text] [Related]
11. Design and characterization of N2-arylaminopurines which selectively inhibit replicative DNA synthesis and replication-specific DNA polymerases: guanine derivatives active on mammalian DNA polymerase alpha and bacterial DNA polymerase III. Wright GE; Baril EF; Brown VM; Brown NC Nucleic Acids Res; 1982 Jul; 10(14):4431-40. PubMed ID: 6812026 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and antibacterial activity of 3-substituted-6-(3-ethyl-4-methylanilino)uracils. Zhi C; Long ZY; Manikowski A; Brown NC; Tarantino PM; Holm K; Dix EJ; Wright GE; Foster KA; Butler MM; LaMarr WA; Skow DJ; Motorina I; Lamothe S; Storer R J Med Chem; 2005 Nov; 48(22):7063-74. PubMed ID: 16250666 [TBL] [Abstract][Full Text] [Related]
13. Development of novel inhibitor probes of DNA polymerase III based on dGTP analogs of the HPUra type: base, nucleoside and nucleotide derivatives of N2-(3,4-dichlorobenzyl)guanine. Butler MM; Dudycz LW; Khan NN; Wright GE; Brown NC Nucleic Acids Res; 1990 Dec; 18(24):7381-7. PubMed ID: 2259629 [TBL] [Abstract][Full Text] [Related]
14. Rational design of substrate analogues targeted to selectively inhibit replication-specific DNA polymerases. Brown NC; Dudycz LW; Wright GE Drugs Exp Clin Res; 1986; 12(6-7):555-64. PubMed ID: 3091344 [TBL] [Abstract][Full Text] [Related]
15. DNA synthesis in vivo in Bacillus subtilis. Andersen JJ J Mol Biol; 1976 Sep; 106(2):285-95. PubMed ID: 824451 [No Abstract] [Full Text] [Related]
16. In vitro antimicrobial activities of novel anilinouracils which selectively inhibit DNA polymerase III of gram-positive bacteria. Daly JS; Giehl TJ; Brown NC; Zhi C; Wright GE; Ellison RT Antimicrob Agents Chemother; 2000 Aug; 44(8):2217-21. PubMed ID: 10898708 [TBL] [Abstract][Full Text] [Related]
17. Localization of the exonuclease and polymerase domains of Bacillus subtilis DNA polymerase III. Barnes MH; Hammond RA; Kennedy CC; Mack SL; Brown NC Gene; 1992 Feb; 111(1):43-9. PubMed ID: 1312503 [TBL] [Abstract][Full Text] [Related]
18. Antibacterial activity and mechanism of action of a novel anilinouracil-fluoroquinolone hybrid compound. Butler MM; Lamarr WA; Foster KA; Barnes MH; Skow DJ; Lyden PT; Kustigian LM; Zhi C; Brown NC; Wright GE; Bowlin TL Antimicrob Agents Chemother; 2007 Jan; 51(1):119-27. PubMed ID: 17074800 [TBL] [Abstract][Full Text] [Related]
19. New DNA polymerase IIIC inhibitors: 3-subtituted anilinouracils with potent antibacterial activity in vitro and in vivo. Svenstrup N; Ehlert K; Ladel C; Kuhl A; Häbich D ChemMedChem; 2008 Oct; 3(10):1604-15. PubMed ID: 18792034 [TBL] [Abstract][Full Text] [Related]